dihydroergotamine has been researched along with Chemical Dependence in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (22.22) | 18.7374 |
| 1990's | 5 (55.56) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Autret-Leca, E; Beau-Salinas, F; Bensouda-Grimaldi, L; Cissoko, H; Jonville-Béra, AP | 1 |
| Dodick, D; Eross, E; Gladstone, J | 1 |
| Kaiser, RS; Primavera, JP | 1 |
| Henn, V | 1 |
| Cano, A; Roquer, J | 1 |
| Barolin, GS | 1 |
| Silberstein, JR; Silberstein, SD | 1 |
| Raskin, NH | 1 |
| Regli, F; Uske, A; Zumstein, V | 1 |
9 other study(ies) available for dihydroergotamine and Chemical Dependence
| Article | Year |
|---|---|
Drug dependence associated with triptans and ergot derivatives: a case/non-case study.
Topics: Claviceps; Dihydroergotamine; Ergotamine; Humans; Migraine Disorders; Oxazolidinones; Piperidines; Pyrrolidines; Risk; Substance-Related Disorders; Sumatriptan; Tryptamines | 2010 |
Chronic daily headache: a rational approach to a challenging problem.
Topics: Adult; Antiemetics; Blood Patch, Epidural; Clinical Protocols; Cluster Headache; Diagnosis, Differential; Dihydroergotamine; Drug Therapy, Combination; Evidence-Based Medicine; Female; Follow-Up Studies; Headache Disorders; Health Services Misuse; Humans; Intracranial Hypertension; Life Change Events; Magnetic Resonance Imaging; Male; Metoclopramide; Patient Education as Topic; Spinal Puncture; Substance-Related Disorders; Trigeminal Neuralgia; Vasoconstrictor Agents | 2003 |
The relationship between locus of control, amount of pre-admission analgesic/ergot overuse, and length of stay for patients admitted for inpatient treatment of chronic headache.
Topics: Attitude to Health; Chronic Disease; Dihydroergotamine; Headache; Humans; Internal-External Control; Length of Stay; Substance-Related Disorders | 1994 |
[The treatment of chronic headache].
Topics: Adrenergic beta-Antagonists; Analgesics; Calcium Channel Blockers; Chronic Disease; Combined Modality Therapy; Dihydroergotamine; Electroencephalography; Female; Headache; Humans; Magnetic Resonance Imaging; Male; Spinal Puncture; Substance-Related Disorders; Tomography, X-Ray Computed | 1993 |
[Ambulatory care of chronic headache secondary to abuse of ergot preparations].
Topics: Administration, Oral; Adult; Aged; Ambulatory Care; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Dihydroergotamine; Ergot Alkaloids; Female; Flunarizine; Headache; Humans; Male; Middle Aged; Naproxen; Prospective Studies; Substance-Related Disorders; Time Factors; Vasodilator Agents | 1996 |
[Drug therapy for headache: (author's transl)].
Topics: Analgesics; Anti-Inflammatory Agents; Antidepressive Agents; Clonidine; Dihydroergotamine; Ergotamine; Headache; Humans; Migraine Disorders; Neuralgia; Pizotyline; Sleep; Substance-Related Disorders; Tranquilizing Agents | 1977 |
Chronic daily headache: long-term prognosis following inpatient treatment with repetitive IV DHE.
Topics: Adult; Aged; Chronic Disease; Dihydroergotamine; Drug Administration Schedule; Female; Follow-Up Studies; Headache; Hospitalization; Humans; Injections, Intravenous; Interviews as Topic; Male; Middle Aged; Prognosis; Substance-Related Disorders; Time Factors | 1992 |
Treatment of status migrainosus: the American experience.
Topics: Acute Disease; Algorithms; Analgesics; Contraindications; Dihydroergotamine; Drug Administration Schedule; Drug Tolerance; Humans; Migraine Disorders; Substance-Related Disorders; United States | 1990 |
[Diffuse cerebral angiopathy with ergotism and persistent neurological disorders].
Topics: Adult; Cerebral Angiography; Cerebral Infarction; Dihydroergotamine; Ergotism; Female; Humans; Substance-Related Disorders | 1987 |